Respiratory stimulants and pulmonary surfactants (Formulary)

DOXAPRAM

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 100mg/5mL (s)

Important: Formulation and dosage details

Formulation:

Infusion 1 gram/500mL

PORACTANT ALFA

Important: Therapy notes

See BNFC.

Important: Formulation and dosage details

Formulation:

Suspension 120mg/1·5mL, 240mg/3mL (specialist use in Specialist Care Baby Unit only)

Editorial Information

Document Id: F362